Redona Therapeutics

Redona Therapeutics is a privately held biotechnology company based in Watertown, Massachusetts. With a small team of 9 employees, the company focuses its efforts on developing innovative therapies for a range of diseases. Redona Therapeutics specializes in the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. Their approach utilizes small molecules to target ncRNA modulating proteins (RMPs), allowing them to precisely control the expression levels of oncogenes and other disease-related proteins. The company's innovative research in ncRNA modulation provides a unique and potentially transformative approach to treating complex diseases. By precisely targeting RMPs, Redona Therapeutics aims to develop targeted therapies with potentially fewer side effects compared to traditional treatments. For more information about Redona Therapeutics and their groundbreaking research, please visit their website at redonatx.com.